Tapewire

Nasdaq · USD

HALO

HALOZYME THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
793
SEC CIK
0001159036
Parsed reports
393

Last 12 months

Inside the activity.

0 purchase rows · 106 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025010
Dec 202505
Jan 202601
Feb 202607
Mar 2026010
Apr 202606
May 2026013
Jun 2026011
Jul 202604
Aug 2026012
Sep 2026011
Oct 2026016

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $13.87 Strike: $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · derivative · entry 9

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 10,000 shares

Expires 2025-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F5 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 6, 2015.

Read SEC document
August 17, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,000 $43.18 $431,820.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · nonDerivative · entry 6

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 623,666

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F4 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $43.04 to $43.34. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 17, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,000 $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · nonDerivative · entry 5

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 633,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $13.87 Strike: $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · derivative · entry 8

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 10,000 shares

Expires 2025-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F5 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 6, 2015.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,000 $43.53 $435,320.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · nonDerivative · entry 4

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 623,666

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F3 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $43.338 to $43.89. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,000 $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · nonDerivative · entry 3

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 633,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $13.87 Strike: $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · derivative · entry 7

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 10,000 shares

Expires 2025-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F5 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 6, 2015.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,000 $43.77 $437,680.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · nonDerivative · entry 2

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 623,666

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F2 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $43.47 to $44.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 21:29 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,000 $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-012364 · form4-08172023_090848.xml · nonDerivative · entry 1

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 633,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 20:04 UTC
Daly James MDirector
SaleCommon Stock 10,000 $43.74 $437,410.00
Disclosure

SEC source: 0001415889-23-012257 · form4-08152023_080821.xml · nonDerivative · entry 2

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,503

F2 · price: Represents a weighted average sales price per share. These shares were sold at prices ranging from $43.54 to $44.16. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 20:04 UTC
Daly James MDirector
SaleCommon Stock 10,000 $43.71 $437,110.00
Disclosure

SEC source: 0001415889-23-012257 · form4-08152023_080821.xml · nonDerivative · entry 1

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,503

F1 · price: Represents a weighted average sales price per share. These shares were sold at prices ranging from $43.63 to $43.86. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
July 27, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $13.87 Strike: $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · derivative · entry 9

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 10,000 shares

Expires 2025-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F5 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 6, 2015.

Read SEC document
July 27, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,000 $43.79 $437,900.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · nonDerivative · entry 6

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 623,666

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F4 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $43.355 to $44.14. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
July 27, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,000 $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · nonDerivative · entry 5

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 633,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

Read SEC document
July 26, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $13.87 Strike: $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · derivative · entry 8

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 10,000 shares

Expires 2025-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F5 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 6, 2015.

Read SEC document
July 26, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,000 $42.69 $426,890.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · nonDerivative · entry 4

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 623,666

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F3 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $42.435 to $42.91. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
July 26, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,000 $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · nonDerivative · entry 3

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 633,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

Read SEC document
July 25, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $13.87 Strike: $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · derivative · entry 7

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 10,000 shares

Expires 2025-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F5 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 6, 2015.

Read SEC document
July 25, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
SaleCommon Stock 10,000 $42.80 $427,960.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · nonDerivative · entry 2

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 623,666

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F2 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $42.48 to $43.08. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
July 25, 2023 Filed Jul 27, 2023 20:03 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,000 $13.87 $138,700.00
Disclosure

SEC source: 0001415889-23-011521 · form4-07272023_080716.xml · nonDerivative · entry 1

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 633,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 20:10 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionOption to Purchase Common Stock · Derivative 2,825 $0.00 Strike: $8.11 $0.00
Disclosure

SEC source: 0001415889-23-011318 · form4-07192023_080758.xml · derivative · entry 7

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,627

Underlying: Common Stock · 2,825 shares

Expires 2026-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This option was granted on February 3, 2016 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 20:10 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionOption to Purchase Common Stock · Derivative 7,175 $0.00 Strike: $13.81 $0.00
Disclosure

SEC source: 0001415889-23-011318 · form4-07192023_080758.xml · derivative · entry 6

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,825

Underlying: Common Stock · 7,175 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This option was granted on February 4, 2015 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 20:10 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $0.00 Strike: $18.41 $0.00
Disclosure

SEC source: 0001415889-23-011318 · form4-07192023_080758.xml · derivative · entry 5

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,505

Underlying: Common Stock · 10,000 shares

Expires 2028-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · derivative.exercise_date: This option was granted on February 14, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 20:10 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionCommon Stock 2,825 $8.11 $22,910.75
Disclosure

SEC source: 0001415889-23-011318 · form4-07192023_080758.xml · nonDerivative · entry 4

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Represents an acquisition of 2,825 shares by the Reporting Person pursuant to a cash exercise and hold transaction.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 20:10 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionCommon Stock 7,175 $13.81 $99,086.75
Disclosure

SEC source: 0001415889-23-011318 · form4-07192023_080758.xml · nonDerivative · entry 3

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 149,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Represents an acquisition of 7,175 shares by the Reporting Person pursuant to a cash exercise and hold transaction.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 20:10 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
SaleCommon Stock 10,000 $40.43 $404,300.00
Disclosure

SEC source: 0001415889-23-011318 · form4-07192023_080758.xml · nonDerivative · entry 2

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,911

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: Represents a weighted average sales price per share. These shares were sold at prices ranging from $40.10 to $40.84. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 20:10 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionCommon Stock 10,000 $18.41 $184,100.00
Disclosure

SEC source: 0001415889-23-011318 · form4-07192023_080758.xml · nonDerivative · entry 1

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 21, 2023 Filed Jun 22, 2023 22:20 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $0.00 Strike: $18.41 $0.00
Disclosure

SEC source: 0001415889-23-010180 · form4-06222023_100619.xml · derivative · entry 3

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,505

Underlying: Common Stock · 10,000 shares

Expires 2028-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · derivative.exercise_date: This option was granted on February 14, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.

Read SEC document
June 21, 2023 Filed Jun 22, 2023 22:20 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
SaleCommon Stock 10,000 $36.00 $360,000.00
Disclosure

SEC source: 0001415889-23-010180 · form4-06222023_100619.xml · nonDerivative · entry 2

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,911

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 21, 2023 Filed Jun 22, 2023 22:20 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionCommon Stock 10,000 $18.41 $184,100.00
Disclosure

SEC source: 0001415889-23-010180 · form4-06222023_100619.xml · nonDerivative · entry 1

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:27 UTC GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007694 · form4-05092023_100504.xml · derivative · entry 2

Posard Matthew L. · CIK 0001543792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:27 UTC GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007694 · form4-05092023_100504.xml · nonDerivative · entry 1

Posard Matthew L. · CIK 0001543792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,254

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person upon completion of service as a director.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:24 UTC GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007693 · form4-05092023_100556.xml · derivative · entry 2

Miyashita Akiko Moni · CIK 0001607742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:24 UTC GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007693 · form4-05092023_100556.xml · nonDerivative · entry 1

Miyashita Akiko Moni · CIK 0001607742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,271

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:21 UTC GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007692 · form4-05092023_100523.xml · derivative · entry 2

MATSUI CONNIE · CIK 0001236537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:21 UTC GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007692 · form4-05092023_100523.xml · nonDerivative · entry 1

MATSUI CONNIE · CIK 0001236537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,004

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:19 UTC GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007691 · form4-05092023_100551.xml · derivative · entry 2

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:19 UTC GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007691 · form4-05092023_100551.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,110

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:14 UTC
Daly James MDirector
GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007689 · form4-05092023_100552.xml · derivative · entry 2

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:14 UTC
Daly James MDirector
GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007689 · form4-05092023_100552.xml · nonDerivative · entry 1

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,503

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:16 UTC GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007690 · form4-05092023_100516.xml · derivative · entry 2

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:16 UTC GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007690 · form4-05092023_100516.xml · nonDerivative · entry 1

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,253

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person upon completion of service as a director.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:12 UTC GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007688 · form4-05092023_100557.xml · derivative · entry 2

Connaughton Bernadette · CIK 0001662521 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:12 UTC GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007688 · form4-05092023_100557.xml · nonDerivative · entry 1

Connaughton Bernadette · CIK 0001662521 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,286

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person upon completion of service as a director.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:09 UTC GrantOption to Purchase Common Stock · Derivative 11,371 $0.00 Strike: $31.00 $0.00
Disclosure

SEC source: 0001415889-23-007687 · form4-05092023_100516.xml · derivative · entry 2

BIZZARI JEAN-PIERRE · CIK 0001630914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,371

Underlying: Common Stock · 11,371 shares

Expires 2033-05-05

F2 · derivative.exercise_date: Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 05, 2023 Filed May 9, 2023 22:09 UTC GrantCommon Stock 8,065 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007687 · form4-05092023_100516.xml · nonDerivative · entry 1

BIZZARI JEAN-PIERRE · CIK 0001630914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,815

F1 · shares: Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
April 18, 2023 Filed Apr 19, 2023 22:07 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $0.00 Strike: $18.41 $0.00
Disclosure

SEC source: 0001415889-23-006740 · form4-04192023_100426.xml · derivative · entry 3

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,505

Underlying: Common Stock · 10,000 shares

Expires 2028-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · derivative.exercise_date: This option was granted on February 14, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.

Read SEC document
April 18, 2023 Filed Apr 19, 2023 22:07 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
SaleCommon Stock 10,000 $36.00 $360,000.00
Disclosure

SEC source: 0001415889-23-006740 · form4-04192023_100426.xml · nonDerivative · entry 2

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,911

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 18, 2023 Filed Apr 19, 2023 22:07 UTC
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER
Exercise / conversionCommon Stock 10,000 $18.41 $184,100.00
Disclosure

SEC source: 0001415889-23-006740 · form4-04192023_100426.xml · nonDerivative · entry 1

LaBarre Michael J. · CIK 0001507174 · SVP, CHIEF TECHNICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 22:04 UTC
Torley HelenDirector · PRESIDENT AND CEO
Exercise / conversionOption to Purchase Common Stock · Derivative 10,000 $14.66 Strike: $14.66 $146,600.00
Disclosure

SEC source: 0001415889-23-004600 · form4-03092023_100317.xml · derivative · entry 9

Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires 2024-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1.

F5 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was January 6, 2014.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.